ACM
OLMA icon

Aquilo Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Aquilo Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-88,875
Closed -$1.1M – 14
2023
Q3 		$1.1M Sell
88,875
-161,125
-64% -$1.64M 0.99% 11
2023
Q2 		$2.26M Buy
+250,000
New +$1.51M 1.25% 11

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aquilo Capital Management's OLMA Position: Q4 2023 in Review

Aquilo Capital Management sold out of Olema Pharmaceuticals (OLMA) in Q4 2023, closing a stake of 88,875 shares — an estimated $1.1M sold.

Aquilo Capital Management first reported a position in OLMA in Q2 2023 and held it in 2 quarters. The position peaked at $2.26M in Q2 2023. 113 funds tracked by Wall St. Rank hold OLMA as of Q4 2023.

  • Aquilo Capital Management reported no remaining Olema Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Aquilo Capital Management sold 88,875 Olema Pharmaceuticals shares in Q4 2023, an estimated $1.1M.
  • Aquilo Capital Management first reported a position in Olema Pharmaceuticals in Q2 2023 and held it in 2 quarters.
  • Aquilo Capital Management's Olema Pharmaceuticals position peaked at $2.26M in Q2 2023.
  • 113 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2023.

Based on Aquilo Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.